US 12,303,430 B2
Glaucoma treatment device
Eugene De Juan, Jr., San Francisco, CA (US); Stephen Boyd, Murrieta, CA (US); Mark E. Deem, Mountain View, CA (US); Hanson S. Gifford, III, Woodside, CA (US); and Dan Rosenman, San Francisco, CA (US)
Assigned to Alcon Inc., Fribourg (CH)
Filed by Alcon Inc., Fribourg (CH)
Filed on Sep. 6, 2023, as Appl. No. 18/462,296.
Application 18/462,296 is a continuation of application No. 17/149,834, filed on Jan. 15, 2021, granted, now 11,786,402.
Application 17/149,834 is a continuation of application No. 15/710,618, filed on Sep. 20, 2017, granted, now 10,905,590.
Application 15/710,618 is a continuation of application No. 14/706,893, filed on May 7, 2015, granted, now 9,789,000.
Application 14/706,893 is a continuation of application No. 11/615,810, filed on Dec. 22, 2006, granted, now 8,721,656.
Claims priority of provisional application 60/824,396, filed on Sep. 1, 2006.
Claims priority of provisional application 60/783,632, filed on Mar. 17, 2006.
Claims priority of provisional application 60/759,835, filed on Jan. 17, 2006.
Prior Publication US 2023/0414410 A1, Dec. 28, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 9/007 (2006.01); A61B 34/00 (2016.01); A61B 90/00 (2016.01); A61F 2/14 (2006.01); A61F 9/00 (2006.01); A61F 9/013 (2006.01); A61F 11/00 (2022.01); A61K 9/00 (2006.01); A61M 27/00 (2006.01)
CPC A61F 9/00781 (2013.01) [A61B 34/70 (2016.02); A61B 90/00 (2016.02); A61F 9/0008 (2013.01); A61F 9/0017 (2013.01); A61F 9/007 (2013.01); A61F 9/00736 (2013.01); A61F 11/00 (2013.01); A61K 9/0051 (2013.01); A61F 2/14 (2013.01); A61F 2/142 (2013.01); A61F 9/0133 (2013.01); A61F 2250/0001 (2013.01); A61F 2250/0096 (2013.01); A61F 2250/0097 (2013.01); A61M 27/002 (2013.01); A61M 2202/04 (2013.01); A61M 2210/0612 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An ocular implant system, comprising:
an ocular implant comprising an elongate core member,
wherein the elongate core member comprises an outer surface, and
wherein the elongate core member comprises a plurality of helical or spiral flow channels defined along the outer surface of the elongate core member; and
a delivery instrument, comprising:
a hand-held component; and
an elongated applier operatively coupled to the hand-held component wherein the elongated applier has an internal lumen and wherein the ocular implant is positioned inside the internal lumen, the elongated applier having a proximal region aligned with a longitudinal axis of the hand-held component and a distal region curved away from the longitudinal axis, wherein the delivery instrument is configured to:
pass the ocular implant across the anterior chamber past the scleral spur near the ciliary body of the eye towards the supraciliary space opposite the incision in the cornea; and
position the ocular implant from inside the anterior chamber such that a proximal end of the ocular implant is in the anterior chamber and a distal end of the ocular implant is in fluid communication with the supraciliary space.